212 related articles for article (PubMed ID: 24326563)
1. Therapy for alopecia areata in mice using parathyroid hormone agonists and antagonists, linked to a collagen-binding domain.
Katikaneni R; Gulati R; Suh D; Sakon J; Seymour A; Ponnapakkam T; Gensure R
J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S61-2. PubMed ID: 24326563
[TBL] [Abstract][Full Text] [Related]
2. Therapy for Alopecia Areata in Mice by Stimulating the Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain.
Katikaneni R; Seymour AW; Gulati R; Ponnapakkam T; Gensure RC
J Investig Dermatol Symp Proc; 2015 Nov; 17(2):13-5. PubMed ID: 26551937
[TBL] [Abstract][Full Text] [Related]
3. Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain.
Katikaneni R; Ponnapakkam T; Suda H; Miyata S; Sakon J; Matsushita O; Gensure RC
Int J Cancer; 2012 Sep; 131(5):E813-21. PubMed ID: 22130912
[TBL] [Abstract][Full Text] [Related]
4. Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model.
Katikaneni R; Ponnapakkam T; Matsushita O; Sakon J; Gensure R
Anticancer Drugs; 2014 Jan; 25(1):30-8. PubMed ID: 24025564
[TBL] [Abstract][Full Text] [Related]
5. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner.
Katikaneni R; Ponnapakkam T; Seymour A; Sakon J; Gensure R
Anticancer Drugs; 2014 Aug; 25(7):819-25. PubMed ID: 24710191
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss.
Tobin DJ; Sundberg JP; King LE; Boggess D; Bystryn JC
J Invest Dermatol; 1997 Sep; 109(3):329-33. PubMed ID: 9284100
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related peptide and the hair cycle - is it the agonists or the antagonists that cause hair growth?
Gensure RC
Exp Dermatol; 2014 Dec; 23(12):865-7. PubMed ID: 25041375
[TBL] [Abstract][Full Text] [Related]
10. A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist.
Peters EM; Foitzik K; Paus R; Ray S; Holick MF
J Invest Dermatol; 2001 Aug; 117(2):173-8. PubMed ID: 11511291
[TBL] [Abstract][Full Text] [Related]
11. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.
Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R
J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005
[TBL] [Abstract][Full Text] [Related]
12. Topical mechlorethamine restores autoimmune-arrested follicular activity in mice with an alopecia areata-like disease by targeting infiltrated lymphocytes.
Tang L; Cao L; Bernardo O; Chen Y; Sundberg JP; Lui H; Chung S; Shapiro J
J Invest Dermatol; 2003 Mar; 120(3):400-6. PubMed ID: 12603852
[TBL] [Abstract][Full Text] [Related]
13. 2-deoxy D-glucose treatment does not elicit a hair growth response in alopecia areata.
Sundberg JP; Silva KA; Kennedy VE; Wilson JJ; Gott NE; Sundberg BA; Roopenian DC
Exp Dermatol; 2019 Sep; 28(9):1091-1093. PubMed ID: 31323149
[TBL] [Abstract][Full Text] [Related]
14. The antiinflammatory effects of Xuefu Zhuyu decoction on C3H/HeJ mice with alopecia areata.
He X; Duan X; Liu J; Sha X; Gong Y; Lu W; Li Z; Chen X; Li Y; Shen Z
Phytomedicine; 2021 Jan; 81():153423. PubMed ID: 33310308
[TBL] [Abstract][Full Text] [Related]
15. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
[TBL] [Abstract][Full Text] [Related]
16. Treatment of alopecia areata in C3H/HeJ mice with the topical immunosuppressant FK506 (Tacrolimus).
Freyschmidt-Paul P; Ziegler A; McElwee KJ; Happle R; Kissling S; Sundberg JP; Hoffmann R
Eur J Dermatol; 2001; 11(5):405-9. PubMed ID: 11525945
[TBL] [Abstract][Full Text] [Related]
17. Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model.
Nakamura M; Jo J; Tabata Y; Ishikawa O
Am J Pathol; 2008 Mar; 172(3):650-8. PubMed ID: 18245811
[TBL] [Abstract][Full Text] [Related]
18. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
Gilhar A; Kalish RS
Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
[TBL] [Abstract][Full Text] [Related]
19. SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.
Gao Z; Jin YQ; Wu W
Oncotarget; 2017 May; 8(20):33432-33443. PubMed ID: 28418931
[TBL] [Abstract][Full Text] [Related]
20. Alopecia areata: A multifactorial autoimmune condition.
Simakou T; Butcher JP; Reid S; Henriquez FL
J Autoimmun; 2019 Mar; 98():74-85. PubMed ID: 30558963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
